Coronavirus envelope protein is a drug target for new platform for the identification and optimization of peptides against SARS-CoV-2

Coronavirus envelope protein is a drug target for new platform for the identification and optimization of peptides against SARS-CoV-2

#####

In your coverage, please use this URL to provide access to the freely available paper in PLOS Biology:   http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002522

Article Title: Developing inhibitory peptides against SARS-CoV-2 envelope protein

Author Countries: United States

Funding: This work was supported by Columbia University Dean’s Office Fund and Columbia University Translational Therapeutics (TRx) Pilot Award (to M.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

END